social_media_phone_iphone_twitter_hand-38920

Russian trolls spread vaccine misinformation on Twitter

August 28, 2018
Manufacturing and Production, Medical Communications, Sales and Marketing Russia, misinformation, public health, study, vaccines

Twitter bots and Russian trolls post content about vaccination at significantly higher rates than normal users, a new study has …

Dompé gives the FDA its first approved neurotrophic keratitis treatment

August 24, 2018
Medical Communications, Sales and Marketing Dompe, FDA, Oxervate, eye disease, pharma

Milan-based biotech firm Dompé has revealed that the FDA has awarded approval in the US to its Oxervate (cenegermin-bkbj ophthalmic …

top_10_image

Top Ten most popular articles on Pharmafile.com this week

August 24, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing India, Ireland, manufacturin, san francisco, top 10

As summer comes to an end manufacturing dominated the news, with jobs lost in both Ireland and San Francisco. Meanwhile …

natural-homeopathic-remedy-alternative-homeopathy-1604071

Homeopathic medicines specialist King Bio enacts nationwide recall

August 24, 2018
Medical Communications asheville, homeopathy, king bio, nc, recall

The Asheville-based drug maker King Bio is recalling 32 children’s medicines because of potential ‘microbial contamination’. The homeopathic medicines specialist …

Generics could save US Medicare $1 billion per year

August 24, 2018
Medical Communications Medicare, United States, branded, generics, marketing, savings

The United States national health insurance programme Medicare could have save $1 billion through the use of generic drugs according …

28246711066_52e38bc591_z

Government publishes no-deal Brexit guidance, health secretary tells pharma companies to stockpile medicines

August 24, 2018
Medical Communications ABPI, EU, UK, brexit, government, stockpiling

The British Government has published a document offering guidance as to what should be expected in the case of a …

GE Healthcare set to open biotech hub in Uppsala, Sweden

August 23, 2018
Manufacturing and Production, Research and Development GE Healthcare, Sweden, Testa Centre, Uppsala, biotech

The American multinational GE Healthcare is opening a 27,000-sq-ft innovation centre in Uppsala, Sweden in an effort to boost the …

astrazeneca-sign

AstraZeneca shocked as inhaler fails to outclass GSK rival in COPD

August 23, 2018
Research and Development AstraZeneca, COPD, GSK, anoro, inhaler, pharma

Researchers at AstraZeneca have been left scratching their heads as new Phase 3b results for its inhaler, Bevespi Aerosphere, posted …

$3 million GSK verdict thrown out of court

August 23, 2018
Sales and Marketing GSK, Litigation, antidepressants, suicide, verdict

A $3 million verdict against British multinational GlaxoSmithKline has been thrown out after a US appeals court said that GSK …

novartis_window

Novartis’ investigational combo impresses in breast cancer sub-group

August 23, 2018
Research and Development Cancer, Novartis, breast cancer, fulvestrant, pharma

Novartis has revealed positive new data for its investigational alpha-specific PI3K inhibitor BYL719 (alpelisib) combined with fulvestrant in the treatment …

vagus_nerve_stimulation

Nerve stimulation treatments improve quality of life in depressed people, study shows

August 23, 2018
Research and Development VNS, depression, neuroscience, psychiatry, quality of life, vagus nerve stimulators

Nerve stimulation treatments can significantly improve depressed people’s quality of life, even in cases in which an individual continues to …

allergan

FDA refuses Allergan’s uterine bleeding therapy with a request for more data

August 22, 2018
Research and Development, Sales and Marketing Allergan, Esmya, FDA, pharma

Allergan has shared the news that the FDA has refused to award marketing authorisation to its ulipristal acetate product Esmya …

34390755362_841335d219_z

Brexit Health Alliance calls for effective planning for no-deal Brexit

August 22, 2018
Research and Development Brexit Health Alliance, Labour, NHS, brexit, no-deal

Niall Dickson, co-chair of the Brexit Health Alliance has called for immediate comprehensive and effective plans for a no deal …

bristol_university_from_cabot_tower

Novo Nordisk buys Bristol University biotech in £620m deal

August 22, 2018
Research and Development Bristol, Novo Nordisk, Ziylo, diabetes

Novo Nordisk has bought a tiny biotech company spun out of Bristol University in a deal that could be worth …

darpa_big_data

Blockchain deployed in fight against fake pharmaceuticals in India

August 22, 2018
Research and Development India, NITI, blockchain, pharma, technology

Indian policymakers in collaboration with an Indian hospital chain and an American multinational, have initiated plans to deploy blockchain technology …

Alex Azar says his agency has the power to eliminate pharmaceutical rebates

August 21, 2018
Research and Development Alex Azar, Rebates, Trump, US government, pbm

US Health and Human Services Secretary Alex Azar has said in an interview with Reuters, that it is within the …

novo_nordisk_flag

Novo’s semaglutide hits the mark in Phase 3 type 2 diabetes study

August 21, 2018
Manufacturing and Production, Research and Development Novo Nordisk, diabetes, pharma, semaglutide, type 2 diabetes

Novo Nordisk has revealed new Phase 3a data on its glucagon-like peptide-1 (GLP-1) analogue oral semaglutide in the treatment of …

28246711066_52e38bc591_z

Leaked letter warns of NHS disruption after Brexit

August 21, 2018
Manufacturing and Production NHS, The Times, brexit, hard Brexit

NHS Providers, the membership organisation and trade association for professionals working in the NHS, has warned that the NHS is …

astrazeneca_sign_sky

Japan approves AstraZeneca’s Tagrisso in EGFRm non-small cell lung cancer

August 21, 2018
Manufacturing and Production, Sales and Marketing AstraZeneca, Cancer, Japan, Tagrisso, lung cancer, pharma

AstraZeneca has revealed that its EGFR tyrosine kinase inhibitor Tagrisso (osimertinib) has been approved in Japan by the nation’s Ministry …

Further six officials fired from China FDA

August 21, 2018
Manufacturing and Production CFDA, Changsheng biotechnology, China, Vaccine, scandal

A further six senior officials from the China Food and Drug Administration (CFDA) have been fired in relation to the …

The Gateway to Local Adoption Series

Latest content